Colefax Group plc Preliminary Results 2022
GSK plc: US FDA Accepts New Drug Application for Momelotinib
GSK plc Statement: Zantac (ranitidine) Litigation Update
Astrazeneca plc sNDA Granted Priority Review in the US
LondonMetric Property Disposal of Four Assets for £26m
Witan Investment Trust plc Half-Year Report 2022
Darktrace plc Receipt of Preliminary Approach
